Ischemic heart disease Board decisions

The Board granted earlier effective dates for the grants of service connection for chronic kidney disease, diabetes mellitus type II, diabetic peripheral neuropathy of all extremities, hypertension, and coronary artery disease, but denied earlier effective dates for bilateral hearing loss and surgical scar of the low back, midline. The Board also remanded claims for service connection for various disabilities.

The Board denied service connection for aortic valve disease, ischemic heart disease (IHD), and hypertension as the evidence did not support a finding that these conditions began during or are related to active service. The claims for squamous cell carcinoma and chloracne were remanded for further development.

The appeal for revision, based on clear and unmistakable error (CUE), of the December 1989 rating decision's denial of service connection for cardiac murmur with thickened aortic valve was denied. The Board also remanded the claim for entitlement to service connection for a heart condition (claimed as aortic valve disease).

The Board granted service connection for a heart disability, to include IHD and CAD, due to presumed exposure to herbicide agents during active military service in Vietnam. The Board also granted a total disability rating based on individual unemployability due to the Veteran's service-connected disabilities.

The Board denied the veteran's claims for an initial compensable disability rating for bilateral hearing loss and an initial disability rating in excess of 10 percent for asbestosis, while remanding a claim for service connection for coronary artery disease.

The Board remands the claims for service connection for CAD, hypertension, and OSA to correct pre-decisional duty to assist errors and obtain additional medical opinions.

The Board dismissed the appeals for service connection for ischemic heart disease, syncope, diabetes mellitus, Type-II, diabetic peripheral neuropathy, bilateral hearing loss, and fracture of two upper teeth due to procedural defects in the Veteran's filings.

The Board remands the claims for service connection for lymphoproliferative disorder, CAD, and DM due to a need for a VA medical opinion.

The Board remands the claims for service connection for ischemic heart disease, diabetes mellitus type II, and peripheral neuropathy of various extremities to obtain additional evidence and ensure adequate medical opinions.

The Board granted an earlier effective date of August 8, 2012, for the award of service connection for coronary artery disease, congestive heart failure with angina, and atrial fibrillation, status post myocardial infarction.

The Board denied service connection for aortic valve disease, ischemic heart disease (IHD), and hypertension as the evidence did not support a finding that these conditions began during or are related to active service. The claims for squamous cell carcinoma, chloracne, and chronic inflammatory demyelinating polyneuropathy were remanded for further development.

The Board granted eligibility to attorney fees based on the past-due benefits awarded in the January 2024 rating decision.

The Board denied the veteran's appeal for an earlier effective date for service connection for hypertension and arteriosclerotic heart disease with valvular heart disease, atrioventricular block, and heart palpitations.

The claims for service connection for peripheral neuropathy in the left and right upper extremities were dismissed as moot, while the claim for an earlier effective date for coronary artery disease was remanded.

The Board denied the appellant's eligibility for direct payment of attorney fees from benefits resulting from the March 2024 grant of past-due benefits.

The Board remands the claims for further development and to correct duty to assist errors.

The appeal for service connection for a heart disorder and a respiratory disorder was dismissed due to the Veteran's death during the pendency of the appeal.

The Board remands the claims for service connection for hypertension, coronary artery disease (CAD), atherosclerosis, kidney disease, and peripheral vascular disease of the bilateral lower extremities to obtain additional medical opinions.

The Board remands the claims for service connection for heart disease, hypertension, diabetes mellitus II, and a skin/skin rash disorder due to the RO's failure to comply with the Board's previous directive.

The Board remands the claims for service connection due to a pre-decisional duty to assist error, as the November 2023 TERA opinions are inadequate.